The effect of N-nitro-L-arginine methyl ester posttreatment on the anticonvulsant effect of phenobarbitone and diazepam on picrotoxin-induced convulsions in rats

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 789-794

  Paul, Vanaja ^a,b  

^a UNIVERSITY OF MADRAS   (India)

^b NONE   (India)

Author keywords

Diazepam; Endogenous NOS inhibitors; L NAME; Phenobarbitone; Picrotoxin

Indexed keywords

4 AMINOBUTYRIC ACID; ARGININE; DIAZEPAM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENOBARBITAL; PICROTOXIN;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEAD MOVEMENT; LIMB MOVEMENT; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0037346786     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00028-5     Document Type: Article

References (39)

1. Albertson T.E., Peterson S.L., Stark L.G. Anticonvulsant effects of diazepam and phenobarbital on prekindled and kindled seizures in rats. Neuropharmacology. 20:1981;597-603.
2. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
3. Borowicz K.K., Kleinrok Z., Czuczwar S.J. Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic agents. Eur. J. Pharmacol. 331:1997;127-132.
4. Borowicz K.K., Starownik R., Kleinrok Z., Czucwar S.J. The influence of L-NG nitroarginine methylester an inhibitor of NOS upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J. Neural Transm. 105:1998;1-12.
5. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T.M., Snyder S.H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal population of the mammalian CNS together with NADPH diaphorase. Neuron. 7:1991;615-624.
6. Buisson A., Lakhmeche M., Verrecchia C., Plotkine M., Boulu R.G. Nitric oxide: an endogenous anticonvulsant substance. NeuroReport. 4:1993;444-446.
7. Catterall W.A. Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol. Sci. 8:1987;57-60.
8. DeSarro G., Gareri P., Falconi U., DeSarro A. 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol. 394:2000;275-288.
9. Deutsch S.I., Rosse R.B., Morn C., Koetzner L., Mastropaolo J. Interference with nitric oxide production and action potentiates the antiseizure efficacy of flurazepam. Pharmacol. Biochem. Behav. 51:1995;133-137.
10. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., Reis D.J. Inhibition of mammalian nitric oxide synthase by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316:1996;247-249.
11. Haefely W.E. GABA and the anticonvulsant action of benzodiazepines and barbiturates. Brain Res. Bull. 5:1980;873-877.
12. Hoogerkamp A., Arends R.H.G.P., Bomers A.M., Mandema J.W., Voskuyl R.A., Danhof M. Pharmacokinetic/pharmacodynamic relationship of benzodiazepine in the direct cortical stimulation model of anticonvulsant effect. J. Pharmacol. Exp. Ther. 279:1996;803-812.
13. Iadecola C., Xu X., Zhang F., Hu J., El-Fakahanv E.E. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitric-L-arginine methyl ester. Neurochem. Res. 19:1994;501-505.
14. Jaffrey S.R., Snyder S.H. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science. 274:1996;774-777.
15. Jayakumar A.R., Sujatha R., Paul V., Puviarasan V.K., Jayakumar R. Involvement of nitric oxide and nitric oxide synthase activity in anticonvulsive action. Brain Res. Bull. 48:1999;387-394.
16. Kielstein J.T., Boger R.H., Bode-Boger S.M., Schaffer J., Barbey M., Koch K.M.et al. Asymmetric dimethyl arginine plasma concentration in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J. Am. Soc. Nephrol. 10:1999;594-600.
17. Kotani K., Ueno S.I., Sano A., Kakimoto Y. Isolation and identification of methylarginine from bovine brain. J. Neurochem. 58:1992;1127-1129.
18. Kuriyama K., Ohkuma S. Role of nitric oxide in control of synaptic transmission: effects on neurotransmitter release. Jpn. J. Pharmacol. 69:1995;1-8.
19. Lonart G., Wang J., Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol. 220:1992;271-272.
20. Macdonald R.L., Bergey G.K. Valproic acid augments GABA mediated postsynaptic inhibition in cultured mammalian neurons. Brain Res. 170:1979;558-562.
21. Macrae I.M., Dawson D.A., Norrie J.D., McCulloch J. Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilization in the rat. J. Cereb. Blood Flow Metab. 13:1993;985-992.
22. Moore P.K., al-Swaych O.A., Evans R. Rabbit brain contains an endogenous inhibitor of endothelium-dependent relaxation. Br. J. Pharmacol. 101:1990;865-868.
23. Mori A., Akagi M., Katyama Y., Watanabe Y. α-Guanidinoglutaric acid in cobalt-induced epileptogenic cerebral cortex of rats. J. Neurochem. 35:1980;603-605.
24. Ohkuma S., Narihara H., Katsura M., Hasegawa T. Nitric oxide-induced (3H)GABA release from cerebral cortical neurons is mediated by peroxynitrite. J. Neurochem. 65:1995;1109-1114.
25. Paul V., Jayakumar A.R. Effects of L-arginine on picrotoxin-induced increase in brain ammonia concentrations and convulsions in rats. Ind. J. Physiol. Pharmacol. 43:1999;479-485.
26. Paul V., Jayakumar A.R. A role of nitric oxide as an inhibitor of γ-aminobutyric acid transaminase in rat brain. Brain Res. Bull. 51:2000;43-46.
27. Paul V., Kazi M. A technique for quantitative measurement of clonic convulsions in rats. Ind. J. Physiol. Pharmacol. 38:1994;125-128.
28. Paul V., Krishnamoorthy M.S. The sex-related difference in the convulsant action of picrotoxin in rats. Ind. J. Physiol. Pharmacol. 32:1988;221-222.
29. Paul V., Subramanian E.H., Rajasekaran K. Pharmacological evidence for a role of γ-aminobutyric acid A receptor mechanism in modulating nitric oxide synthase activity in rat brain. Neurochem. Int. 38:2001;209-211.
30. Penix L.P., Davis W., Subramaniyam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res. 18:1994;177-184.
31. Rajasekaran K., Paul V. Effect of L-NAME, an inhibitor of nitric oxide synthesis on motor behaviour in rats. Med. Sci. Res. 27:1999;609-612.
32. Rees D.D., Palmer R.M.J., Schultz R., Hudson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
33. Rundfeldt C., Koch K., Richter A., Mevissen M., Gerecke U., Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizures threshold in a cortical stimulation model in rats. Eur. J. Pharmacol. 274:1995;73-81.
34. Segovia G., Mora F. Role of nitric oxide in modulating the release of dopamine, glutamate and GABA in striatum of the freely moving rat. Brain Res. Bull. 45:1998;275-280.
35. Shiraga H., Hiramatsu M., Mori A. Convulsive activity of α-guanidinoglutaric acid and the possible involvement of 5-hydroxytryptamine in the α-guanidinoglutaric acid-induced seizures mechanism. J. Neurochem. 17:1986;1832-1836.
36. Silvilotti L., Nistri A. A GABA receptor mechanism in the central nervous system. Prog. Neurobiol. 36:1991;35-92.
37. Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boger R.H., Bode-Boger S.M.et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 33:1999;652-658.
38. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339:1992;572-575.
39. Yokoi I., Kabuto H., Habu H., Mori A. α-Guanidinoglutaric acid, an endogenous convulsant as a novel nitric oxide synthase inhibitor. J. Neurochem. 63:1994;1565-1567.